Achillion Pharmaceuticals Stock Fundamentals
Achillion Pharmaceuticals fundamentals help investors to digest information that contributes to Achillion Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Achillion Pink Sheet. The fundamental analysis module provides a way to measure Achillion Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Achillion Pharmaceuticals pink sheet.
Achillion |
Achillion Pharmaceuticals Company Shares Outstanding Analysis
Achillion Pharmaceuticals' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Achillion Pharmaceuticals Shares Outstanding | 30 M |
Most of Achillion Pharmaceuticals' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Achillion Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Achillion Pharmaceuticals has 30 M of shares currently outstending. This is 99.32% lower than that of the Communication Services sector and significantly higher than that of the Advertising Agencies industry. The shares outstanding for all United States stocks is 94.75% higher than that of the company.
Achillion Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Achillion Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Achillion Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Achillion Pharmaceuticals competition to find correlations between indicators driving Achillion Pharmaceuticals's intrinsic value. More Info.Achillion Pharmaceuticals is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Achillion Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Achillion Pharmaceuticals' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Achillion Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Achillion Pharmaceuticals' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Achillion Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Achillion Pharmaceuticals by comparing valuation metrics of similar companies.Achillion Pharmaceuticals is currently under evaluation in shares outstanding category among its peers.
Achillion Fundamentals
| Return On Equity | -0.0023 | |||
| Return On Asset | -115.43 | |||
| Operating Margin | (586.17) % | |||
| Current Valuation | 6.21 M | |||
| Shares Outstanding | 30 M | |||
| Shares Owned By Insiders | 97.61 % | |||
| Number Of Shares Shorted | 16.38 M | |||
| Price To Earning | (23.49) X | |||
| Price To Book | 4.00 X | |||
| Price To Sales | 710.14 X | |||
| Revenue | 8.7 K | |||
| Gross Profit | 7.87 K | |||
| EBITDA | (43.34 K) | |||
| Net Income | (51 K) | |||
| Cash And Equivalents | 1.44 K | |||
| Total Debt | 61 K | |||
| Debt To Equity | 1.00 % | |||
| Current Ratio | 0.02 X | |||
| Cash Flow From Operations | (39.76 K) | |||
| Short Ratio | 7.89 X | |||
| Earnings Per Share | (0) X | |||
| Price To Earnings To Growth | (0.66) X | |||
| Number Of Employees | 56 | |||
| Beta | 1.59 | |||
| Market Capitalization | 6.18 M | |||
| Total Asset | 464.52 M | |||
| Retained Earnings | (653.45 M) | |||
| Working Capital | 447.93 M | |||
| Current Asset | 462.59 M | |||
| Current Liabilities | 14.66 M | |||
| Z Score | 59.2 |
Pair Trading with Achillion Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Achillion Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achillion Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Achillion Pink Sheet
If you are still planning to invest in Achillion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achillion Pharmaceuticals' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |